Ligand validation:4CYV

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4CYV designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4CYV_NAG_E_420	17%	41%	0.303	0.883	0.54	1.79	-	4	0	1	100%	0.9333
4CYV_NAG_A_401	15%	42%	0.3	0.858	0.55	1.72	-	3	0	1	100%	0.9333
4CYV_NAG_A_420	8%	39%	0.332	0.803	0.57	1.85	-	3	0	1	100%	0.9333
4CYV_NAG_C_420	7%	25%	0.282	0.733	0.6	2.58	-	4	0	1	100%	0.9333
4CYV_NAG_B_211	6%	49%	0.294	0.737	0.68	1.27	-	3	0	0	100%	0.9333
4CYV_NAG_D_211	2%	47%	0.353	0.637	0.73	1.32	1	2	1	0	100%	0.9333
4QY2_NAG_J_601	77%	74%	0.099	0.937	0.44	0.55	-	-	0	0	100%	0.9333
4QY1_NAG_D_601	76%	85%	0.109	0.947	0.3	0.44	-	-	1	0	100%	0.9333
4WSX_NAG_K_401	76%	24%	0.097	0.933	0.46	2.78	-	3	0	0	100%	0.9333
4QY0_NAG_J_601	68%	79%	0.132	0.945	0.35	0.51	-	-	0	0	100%	0.9333
6TWV_NAG_J_201	67%	48%	0.115	0.925	0.33	1.66	-	1	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.81	0.95	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	99%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.